EcoDrugPlus

Carbonic Anhydrase 14

Ensembl ID : ENSPLAG00000018041
Gene Symbol: CA14
3 Cross references
210 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSPLAG00000015537
Gene Symbol: LOC106952796
3 Cross references
196 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSPLAG00000015614
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSPLAG00000003205
Gene Symbol: CA6
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSPLAG00000008508
Gene Symbol: CA7
3 Cross references
221 Possible Orthologues:

Carbonic Anhydrase 7-Like

Ensembl ID : ENSPLAG00000009086
Gene Symbol: LOC106935124
2 Cross references
79 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSPLAG00000012366
Gene Symbol: CA4A
1 Cross references
212 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSPLAG00000000009
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase I Isoform Epsilon-Like

Ensembl ID : ENSPLAG00000001429
Gene Symbol: LOC106951307
3 Cross references
196 Possible Orthologues:

Caspase 9

Ensembl ID : ENSPLAG00000008026
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSPLAG00000021472
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSPLAG00000017822
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).